• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a new antiepileptic agent without hypnotic effects

Research Project

Project/Area Number 11557059
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section展開研究
Research Field Pediatrics
Research InstitutionTohoku University

Principal Investigator

IINUMA Kazuie  Tohoku University, Department of Pediatrics Professor, 大学院・医学系研究科, 教授 (80004927)

Co-Investigator(Kenkyū-buntansha) MASUDA Yoshinobu  Dainippon Pharmaceutical Co.Chief Researcher, 創薬研究所, 主任研究員
YOKOYAMA Hiroyuki  Tohoku University, Department of Pediatrics Research Associate, 医学部・附属病院, 助手 (40271952)
HAGINOYA Kazuhiro  Tohoku University, Department of Pediatrics Lecturer, 大学院・医学系研究科, 講師 (00208414)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsPTZ kindling / methylhistamine / H3-receptor / H1受容体ノックアウトマウス
Research Abstract

Epilepsy model was developed in ICR mice according to daily intraperitoneal(ip)injection of pentylentetrazol(PTZ). The daily ip administration of 40mg of PTZ induced generalized convulsion about 25 days after the initial injection. The phenomenon of kindling formation showed dose dependency of PTZ.
Histamine H3-receptors control the release of histamine from the histaminegic neurons in the central nervous system. The H3-receptor inhibits the histamine release.
Daily ip administration of methylhistamine, an agonist of H3-receptor induced an acceleration of PTZ kindling. The strage 5 convulsion was developed in 100%. mice 8 days after the PTZ administration. The duration of seizures was prolonged and the latency after injection was shortened in mice administered 10mg of methylhistamine than those with 5mg of methylhistamine. These results imply that convulsive seizures were accelerated through H3-receptors probably due to inhibition of histamine release. We speulate that histamine H3-receptor antagonist may inhibit the development the PTZ kindling. This experiment is the next project.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] 飯沼一宇: "中枢ヒスタミンと痙攣"別冊・医学のあゆみ「ヒスタミン研究の最近の進歩」. 94-96 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kazuie Iinuma: "Central histaminergic neuron system and convulsion"Journal of Clinical and Experimental Medicine. 94-96 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 飯沼一宇: "中枢ヒスタミンと痙攣"別冊・医学のあゆみ「ヒスタミン研究の最近の進歩」. 94-96 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi